- Home
- KROS vs LDP Comparison
KROS vs LDP Comparison
Compare KROS & LDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- LDP
- Stock Information
- Founded
- KROS 2015
- LDP 2012
- Country
- KROS United States
- LDP United States
- Employees
- KROS N/A
- LDP N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- LDP Finance Companies
- Sector
- KROS Health Care
- LDP Finance
- Exchange
- KROS Nasdaq
- LDP Nasdaq
- Market Cap
- KROS 589.8M
- LDP 607.2M
- IPO Year
- KROS 2020
- LDP N/A
- Fundamental
- Price
- KROS $11.85
- LDP $20.60
- Analyst Decision
- KROS Buy
- LDP
- Analyst Count
- KROS 11
- LDP 0
- Target Price
- KROS $45.33
- LDP N/A
- AVG Volume (30 Days)
- KROS 1.9M
- LDP 102.5K
- Earning Date
- KROS 02-26-2025
- LDP 01-01-0001
- Dividend Yield
- KROS N/A
- LDP 7.91%
- EPS Growth
- KROS N/A
- LDP N/A
- EPS
- KROS N/A
- LDP N/A
- Revenue
- KROS $651,000.00
- LDP N/A
- Revenue This Year
- KROS $303.27
- LDP N/A
- Revenue Next Year
- KROS N/A
- LDP N/A
- P/E Ratio
- KROS N/A
- LDP N/A
- Revenue Growth
- KROS 8037.50
- LDP N/A
- 52 Week Low
- KROS $9.78
- LDP $16.16
- 52 Week High
- KROS $73.00
- LDP $20.30
- Technical
- Relative Strength Index (RSI)
- KROS 22.59
- LDP 50.34
- Support Level
- KROS $10.95
- LDP $20.11
- Resistance Level
- KROS $11.63
- LDP $20.63
- Average True Range (ATR)
- KROS 0.84
- LDP 0.23
- MACD
- KROS 1.22
- LDP 0.06
- Stochastic Oscillator
- KROS 23.90
- LDP 77.14
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.